Number of FDA approvals for CAR-T cell therapies 2024

From 2019 to 2024, the number of FDA regulatory approvals for CAR-T cell therapies is expected to increase from two approvals to an estimated 21 approvals. This statistic depicts the number of FDA regulatory approvals for CAR-T cell therapies from 2012 to 2024.

Number of FDA regulatory approvals for CAR-T cell therapies in 2012, 2019, and 2024*

Characteristic	Number of FDA approvals
2012	0
2019**	2
2024**	21

0510152025

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2019

More information

Region

United States

Survey time period

as of December 2019

Supplementary notes

* FDA regulatory approvals: notifiable disease per biologic license application for CAR-T.
** Projection as of October 16, 2019.

Citation formats

Other statistics on the topic

Deaths by cancer in the U.S. from 1950 to 2022 (per 100,000 population)

State of Health

Deaths by cancer in the U.S. 1950-2022

Distribution of the 10 leading causes of death in the United States in 2022

State of Health

Leading causes of death in the United States 2022

Deaths due to breast cancer in the U.S. from 1950 to 2022 (per 100,000 population)

State of Health

Deaths from breast cancer in the U.S. 1950-2022

Percentage of U.S. adults that thought select health issues were most important for the U.S. as of 2019 and 2024

Health System

Most important health issues facing the U.S. according to U.S. adults 2024

Access all statistics starting from $2,388 USD yearly ^*

* For commercial use only

For single users

$0 USD

Always free

Access limited to Free Statistics. Premium Statistics are not included.

Free Statistics

Based on your interests

For single users

$199 USD

per month, billed annually ¹

Buy now

Free Statistics
Premium Statistics

For teams of up to 5 people

$1,299 USD

per month, billed annually ¹

Buy now

Free + Premium Statistics
Reports
Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Leading companies trust Statista:

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.

Marlene Greenfield
Vice President, Hearst Magazines